Skip to main content

Month: May 2022

Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference

SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will be participating at the Spring Into Action Best Ideas Virtual Investor Conference. The conference is taking place virtually from May 16 – 20, 2022. Details for access to the presentation are as follows: Spring Into Action Virtual ConferenceDate: Monday, May 16, 2022Time: 1:00 PM EDTEvent: PresentationTo register for the conference, click HERE. For additional information on Achieve visit https://ir.achievelifesciences.com About Achieve and Cytisinicline Tobacco use is currently the leading cause of preventable death that is responsible...

Continue reading

Alliance Creative Group (ACGX) Reports Revenue of $2,865,404 for First Quarter of 2022

Quarterly Revenues Increased $251,407 compared to 2021 for a 9.6% increase Chicago, IL , May 13, 2022 (GLOBE NEWSWIRE) — Alliance Creative Group, Inc., (http://www.AllianceCreativeGroup.com) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Three Months Ending March 31, 2022. Revenues for the quarter ending March 31, 2022 (“Q1 2022”) were $2,865,404 Gross Profits for the quarter ending March 31, 2022 (“Q1 2022”) were $632,021 Net Income for the quarter ending March 31, 2022 (“Q1 2022”)  were $75,529 The total assets on the Balance Sheet for the Alliance Creative Group as of 03/31/22 were $3,873,726. The total outstanding common shares as of March 31, 2022 (“Q1 2022”)  were 2,149,611 with 1,423,971 of those shares in the float.   The Company ended the quarter with $16,608 Cash on hand. Total Stockholder...

Continue reading

Oxford Lane Capital Corp. Awarded “Best Public Closed‐End CLO Fund” by Creditflux 

GREENWICH, Conn., May 13, 2022 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) has been named “Best Public Closed-End CLO Fund” by Creditflux, a leading global information source covering credit funds and CLOs. The award was presented at Creditflux’s Credit Symposium and Manager Awards, which took place in London on May 10th. The annual Creditflux Manager Awards recognize leading managers and funds based purely on data over the applicable review period. The “Best Public Closed-End CLO Fund” award category measured the change in value of eligible funds between December 31, 2020 and December 31, 2021. “We are pleased to have received this recognition from Creditflux,” said...

Continue reading

AvePoint to Participate at Upcoming Conferences

JERSEY CITY, N.J., May 13, 2022 (GLOBE NEWSWIRE) — AvePoint (NASDAQ: AVPT), the most advanced SaaS and data management platform provider, today announced that management is scheduled to present at upcoming investor conferences. Details for each event are as follows:Needham 17th Annual Technology & Media Conference, Tuesday May 17th, 2022 at 4:30 p.m. ETJefferies Software Conference, Wednesday June 1st, 2022 at 3:30 p.m. ETCowen 50th Annual Technology, Media & Telecom Conference, Thursday June 2nd, 2022 at 9:05 a.m. ETWilliam Blair 42nd Annual Growth Stock Conference, Thursday June 9th, 2022 at 11:00 a.m. ETA live and archived audio webcast of the presentations will be available on the Investor Relations website here.  About AvePoint Collaborate with confidence. AvePoint provides the most advanced platform for...

Continue reading

Medallion Strengthens Its Up-List Plan to Facilitate Dual Listing in the U.S. and Canada

VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) — Medallion Resources Ltd. (TSX-V: MDL; OTCQB: MLLOF; Frankfurt: MRDN – “Medallion” or the “Company”) is pleased to announce that it plans to introduce a resolution at its upcoming Annual General and Special Meeting of Shareholders (the “Shareholders’ Meeting”) to enable the Company’s common shares to continue trading on the TSX Venture Exchange (“TSX-V”) after the planned listing on the Nasdaq Capital Market (“NasdaqCM”). In its news release dated April 26, 2022, Medallion announced a new strategic plan to position the Company in the near term as a technology leader within the industries essential to the generation, storage, and efficient use of clean energy. Key parts of the plan include a strengthened executive leadership team, listing its common shares on NasdaqCM,...

Continue reading

Northpath Investments Acquires 323 Bergen Boulevard in Bergen County, NJ

NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) — Northpath Investments has acquired 323 Bergen Boulevard, an industrial/flex facility in Fairview, NJ for $5.1M, to add to its growing portfolio of industrial/flex assets. The 29,822 Sq foot industrial/flex facility is 100% leased to Fairview Health Club, a local gym/fitness operator that has leased the entire property since opening its doors in 2013. Northpath secured debt for this transaction off-market through a direct relationship with the lender. “We are thrilled to add another industrial property to our portfolio” said Gershon Alexander, Principal at Northpath Investments. “We are bullish on the fundamentals of the asset class in Northern Jersey and believe this asset is well positioned to capture the exponential growth in the market for our investors”. New Jersey has seen unprecedented...

Continue reading

Icanic Brands Announces Non-Binding LOI to Acquire DNA Organics, Inc. (Lifted Organics) and THC Engineering Share Issuance

VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) — Icanic Brands Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Icanic Brands” or the “Company”), a multi-state brand operator of premium cannabis brands in California, is pleased to announce that it has signed a non-binding Letter of Interest (“LOI”) to acquire DNA Organics, Inc. (“Lifted”), a premium California cultivator and manufacturer (the “Proposed Acquisition”). About LiftedLifted is a vertically integrated California cannabis company specializing in cultivation and solventless manufacturing using sustainable, organic practices with a focus on achieving economies of scale through adoption and adaptation of existing commercial agriculture and manufacturing solutions.  Lifted was founded in 2012 after the passage of California Proposition 215 and has over 10 years of successful...

Continue reading

QuoteMedia Announces 18% Revenue Growth for Q1 2022

PHOENIX, May 13, 2022 (GLOBE NEWSWIRE) — QuoteMedia, Inc. (OTCQB: QMCI), a leading provider of market data and financial applications, announced financial results for the quarter ended March 31, 2022. QuoteMedia provides banks, brokerage firms, private equity firms, financial planners and sophisticated investors with a more economical, higher quality alternative source of stock market data and related research information. We compete with several larger legacy organizations and a modest community of other smaller companies. QuoteMedia provides comprehensive market data services, including streaming data feeds, on-demand request-based data (XML/JSON), web content solutions (financial content for website integration) and applications such as Quotestream Professional desktop and mobile.  Highlights for Q1 2022 include the following:Quarterly...

Continue reading

Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results

Conference call scheduled for 8:30 a.m. ET today MIAMI, May 13, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today provided a business update and reported its financial results for the first quarter ended March 31, 2022. First Quarter Business Updates: Lomecel-B for Alzheimer’s Disease:In January 2022, we initiated enrollment in a 48-patient, 4-arm, parallel design, randomized (1:1:1:1) Phase 2a clinical trial of Lomecel-B infusion in patients with mild Alzheimer’s disease. The Phase 2a study is intended to evaluate the safety of single and multiple infusions of two different dose levels of Lomecel-B compared to placebo. Other endpoints include...

Continue reading

Progressive Care to Report First Quarter Financial Results on May 17, 2022

Progressive Care Inc. Has Scheduled an Investor Conference Call for 4:30 PM ET on Tuesday, May 17, 2022 MIAMI, FL, May 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company (the “Company” or “Progressive Care”), is pleased to announce that the Company has scheduled an investor conference call for 4:30 PM ET on Tuesday, May 17, 2022. See on website Chairman and CEO, Alan Jay Weisberg, stated, “We are looking forward to providing our shareholders with our first quarter results, Company’s vision for the rest of 2022, and an update regarding our progress towards uplisting to Nasdaq.” Those attending the investor conference call will have the opportunity to submit questions concerning the Company in advance to Stuart Smith of SmallCapVoice.Com, Inc....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.